Covid-19: SARS-CoV-2 genomic surveillance
- Funded by Federal Office of Public Health (FOPH)
- Total publications:24 publications
Grant number: 54231
Grant search
Key facts
Disease
COVID-19, UnspecifiedStart & end year
2024Known Financial Commitments (USD)
$1,670,627Funder
Federal Office of Public Health (FOPH)Principal Investigator
Schneider KatrinResearch Location
SwitzerlandLead Research Institution
N/AResearch Priority Alignment
N/A
Research Category
Epidemiological studies
Research Subcategory
Disease surveillance & mapping
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
The aim of this contract is to ensure national genomic surveillance of the SARS-CoV-2 virus. This virus can continuously change through mutations, resulting in multiple variants circulating. Genomic surveillance will focus on virus variants that cause severe illness and lead to hospitalization, as well as virus variants that could impact clinical care or vaccine efficacy, and samples from the Sentinella surveillance system. In addition (outside the scope of this contract), wastewater sequencing (wastewater monitoring) will be conducted to monitor circulating virus variants in the population. The subsidy from this contract will enable the continuation of the national genomic surveillance program for the SARS-CoV-2 virus and its expansion to include influenza and RSV (respiratory virus).
24 Publications linked via Europe PMC
Last Updated:2 days ago
View all publications at Europe PMC